“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart
Article: Sarcoidosis in a metastatic melanoma patient treated with the CTLA-4 inhibitory monoclonal antibody ipilimumab
Sarcoidosis in a metastatic melanoma patient treated with the CTLA-4 inhibitory monoclonal antibody ipilimumab
Reviews
There are no reviews yet.
Be the first to review “Article: Sarcoidosis in a metastatic melanoma patient treated with the CTLA-4 inhibitory monoclonal antibody ipilimumab” Cancel reply
Reviews
There are no reviews yet.